Investor Presentaiton
Strategies for $ 13bn Brazilian pharma market
Set up Zydus Healthcare Brazil Ltda. (100%
subsidiary) to enter generics market in 2005-06
Filed 64 dossiers so far for generic and
branded products from India, of which 23
have been approved.
Launched 14 generic products so far
Acquired Nikkho in 2007-08 to foray into the
fast growing, profitable and sustainable
branded generics segment
Sales in Brazil (Rs. Mio.)
1,628
▲ 12%
1,818
▲ 24%
2,250
FY 08-09
FY 09-10
FY 10-11
A profit-making co., Nikkho has a mfg. facility and strong marketing and
distribution network in Brazil
Expanded the branded basket to over 25 products with launch of several new
brands from India and a few acquired brands
Planning to increase product portfolio in both branded and generics market
with 8-10 launches every year
13View entire presentation